WSC SPOTLIGHT: SEPSIS, PANDEMICS, AND ANTIMICROBIAL RESISTANCE – GLOBAL HEALTH THREATS OF THE 21ST CENTURY by WHO AND GSA 9 SEPTEMBER 2020
The congress has concluded. All sessions were recorded and have been released in 6 separate presentations via YouTube and as a podcast on Apple Podcasts.
View the program Program+WSC+Spotlight+2020
Welcome Remarks by the Program Chairs WHO & GSA. See: https://wscspotlight.org/
Session 1 – Opening Session View Session 1
- WHO Response to Global Health Threats: Sepsis, AMR, and COVID-19
Tedros Adhanom Ghebreyesus, Director-General, World Health Organization, Switzerland - Entering a New Era for Tackling AMR
Hanan Balkhy, Assistant Director-General, World Health Organization, Switzerland - Keynote: The Next Generation of Environmentally Friendly Antibiotics
Ada Yonath, Nobel Prize Laureate, Weizmann Institute of Science, Israel - Vaccination Saves Lives through Prevention of Sepsis
Seth Berkley, GAVI, the Vaccine Alliance, Switzerland - The Patient Safety Dimension
Liam Donaldson, WHO Envoy for Patient Safety, United Kingdom
Session 2 – The Epidemiology and Burden of Sepsis View Session 2
- Keynote: The Global Burden of Sepsis
Kristina Rudd, University of Pittsburgh, United States of America - The Burden of Maternal Sepsis in Fragile Populations
Zenaida Recidoro, National Safe Mother Program Department of Health, Philippines - The Burden of Sepsis in Children and Neonates: Lessons Learned from Lowand Middle-Income Countries (LMICs)
Matthew Westercamp, Centers for Disease Control and Prevention, United States of America - Challenges in Implementing Sepsis and AMR Surveillance
Uduak Okomo, Medical Research Council Unit The Gambia at London School of
Hygiene and Tropical Medicine, The Gambia - Drivers of and Inequalities in the Burden of Sepsis in LMICs
Flavia Machado, Global Sepsis Alliance, Brazil
Session 3 – Antimicrobial Resistance: An Emerging Global Health Threat View Session 3
- Keynote: One-Health-Approach to AMR and Global Health Threats
Ilaria Capua, Emerging Pathogens Institute, University of Florida, United States of America - Novel Medicines Project: Driving Reinvestment in Research and Development and Responsible Antibiotic Use
Stephan Harbarth, Infection Control Programme, Geneva University Hospitals, Switzerland - Cost-Effective Interventions to Combat AMR
Imran Hasan, International Centre for Diarrhoeal Disease Research, Bangladesh - AMR in Neonates and Children with Sepsis in LMICs
Mike Sharland, St George‘s University Hospitals NHS Foundation Trust, United Kingdom - Antimicrobial Stewardship in Limiting Multi Drug Resistant Organisms
Jameela Alsalman, Ministry of Health, Bahrain
Session 4 – Sepsis, Ebola, and COVID-19 View Session 4
- Keynote: WHO Clinical Response to Sepsis, COVID-19, and Ebola
Janet Diaz, World Health Organization, United States of America - Managing Sepsis in COVID-19 Patients – Special Considerations
Hala Abuzeid, Abu Dhabi Health Service, United Arab Emirates - COVID-19 Therapeutics: What We Have Learned and Where We Are Going
Marco Cavaleri, European Medicines Agency, The Netherlands - Mobile Emergency Care Units Ebola Sepsis Improve Survival
Richard Kojan, The Alliance for International Medical Action, Democratic Republic of the Congo - Inflammatory Response Due to COVID-19 Infection
Yee Sin Leo, National Centre for Infectious Diseases, Singapore
Session 5 – A Comprehensive and Integrated Approach to Preventing Sepsis and AMR View Session 5
- Keynote: Preventing Infection and Improving Health in LMICs: Lessons
Learned from Water, Sanitation, and Hygiene Programmes Kelly Ann Naylor, UNICEF, United States of America - WHO Infection Prevention and Control Strategy to Prevent AMR and Sepsis
Benedetta Allegranzi, World Health Organization, Switzerland - The Impact of Bacillus Calmette-Guérin (BCG) Vaccination on COVID-19 and Respiratory Infections
Evangelos Giamarellos, European Sepsis Alliance, Greece - Aspects of AMR and Appropriate Antimicrobial Use in Critically Ill Patients
Mervyn Mer, University of the Witwatersrand, Johannesburg, South Africa
Session 6 – Early Identification and Appropriate Clinical Management of Sepsis Saves Lives and Prevents AMR View Session 6
- Keynote: Bringing the Fight Against Sepsis to the Next Level
Konrad Reinhart, Global Sepsis Alliance, Germany - Management and Treatment of Possible Serious Bacterial Infection in Infants in Resource-Limited Settings
Shally Awasthi, King George‘s Medical University, India - The Role of the Pathogen in the Management of Sepsis
Arjen Dondorp, Asia Pacific Sepsis Alliance, Thailand - Pediatric Sepsis: Guidelines and More
Rana Sharara-Chami, American University of Beirut Medical Center, Lebanon - The Role of Sepsis and AMR for Patient Safety
Abdulelah Al-Hawsawi, Saudi Patient Safety Center, Saudi Arabia - Closing Remarks:
Edward Kelley, Director, Integrated Health Services, WHO, Switzerland
Niranjan ’Tex’ Kissoon, GSA, Canada
